spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, C. J.
Right arrow Articles by Stringer, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robinson, C. J.
Right arrow Articles by Stringer, S. E.
Abe, K., Shoji, M., Chen, J., Bierhaus, A., Danave, I., Micko, C., Casper, K., Dillehay, L., Nawroth, P. P. and Rickles, F. R (1999). Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc. Nat. Acad. Sci. USA 96, 8663-8668.[Abstract/Free Full Text]

Achen, M. G., Jeltsch, M., Kukk, E., Makinen, T., Vitali, A., Wilks, A. F., Alitalo, K. and Stacker, S. A (1998). Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk-1) and VEGF receptor 3 (Flt-4). Proc. Nat. Acad. Sci. USA 95, 548-553.[Abstract/Free Full Text]

Akiri, G., Nahari, D., Finkelstein, Y., Le, S. Y., Elroy-Stein, O. and Levi, B. Z (1998). Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription. Oncogene 17, 227-236.[Medline]

Alon, T., Hemo, I., Itin. A., Pe'er. J., Stone, J. and Keshet, E (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med 10, 1024-1028.

Anthony, F. W., Wheeler, T., Elcock, C. L., Pickett, M. and Thomas, E. J (1994). Short report: identification of a specific pattern of vascular endothelial growth factor mRNA expression in human placenta and cultured placental fibroblasts. Placenta 15, 557-561.[Medline]

Asahara, T., Bauters, C., Zheng, L. P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J. F. and Isner, J. M (1995). Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92, 365-371.[Abstract/Free Full Text]

Bacic, M., Edwards, N. A. and Merrill, M. J (1995). Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues. Growth Factors 12, 11-15.[Medline]

Barleon, B., Sozzani, S., Zhou, D., Weich, H. A., Mantovani, A. and Marme, D (1996). Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor Flt-1. Blood 87, 3336-3343.[Abstract/Free Full Text]

Barleon, B., Totzke, F., Herzog, C., Blanke, S., Kremmer, E., Siemeister, G., Marme, D. and Martiny-Baron, G (1997). Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. J. Biol. Chem 272, 10382-10388.[Abstract/Free Full Text]

Barleon, B., Siemeister, G., Martiny-Baron, G., Weindel, K., Herzog, C. and Marme, D (1997). Vascular endothelial growth factor up-regulates its receptor fms -like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 57, 5421-5425.[Abstract/Free Full Text]

Benjamin, L. E. and Keshet, E (1997). Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Nat. Acad. Sci. USA 94, 8761-8766.[Abstract/Free Full Text]

Boensch, C., Kuo, M. D., Connolly, D. T., Huang, S. S. and Huang, J. S (1995). Identification, purification, and characterization of cell-surface retention sequence-binding proteins from human SK-Hep cells and bovine liver plasma membranes. J. Biol. Chem 270, 1807-1816.[Abstract/Free Full Text]

Brogi, E., Wu, T., Namiki, A. and Isner, J. M (1994). Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 2, 649-652.

Brogi, E., Schatteman, G., Wu, T., Kim, E. A., Varticovski, L., Keyt, B. and Isner, J. M (1996). Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J. Clin. Invest 97, 469-476.[Medline]

Cai, H. and Reed, R. R (1999). Cloning and characterization of neuropilin-1-interacting protein: a PSD-95/Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1. J. Neurosci 19, 6519-6527.[Abstract/Free Full Text]

Cao, Y., Chen, H., Zhou, L., Chiang, M. K., Anand-Apte, B., Weatherbee, J. A., Wang, Y., Fang, F., Flanagan, J. G. and Tsang, M. L (1996). Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J. Biol. Chem 271, 3154-3162.[Abstract/Free Full Text]

Cao, Y., Ji, W. R., Qi, P., Rosin, A. and Cao, Y (1997). Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. Biochem. Biophys. Res. Commun 235, 493-498.[Medline]

Cao, Y., Linden, P., Farnebo, J., Cao, R., Eriksson, A., Kumar, V., Qi, J. H. Claesson-Welsh, L. and Alitalo, K (1998). Vascular endothelial growth factor C induces angiogenesis in vivo. Proc. Nat. Acad. Sci. USA 95, 14389-14394.[Abstract/Free Full Text]

Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W. and Nagy, A (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.[Medline]

Chen, H., Chedotal, A., He, Z., Goodman, C. S. and Tessier-Lavigne, M (1997). Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Neuron 19, 547-559.[Medline]

Cheung, C. Y., Singh, M., Ebaugh, M. J. and Brace, R. A (1995). Vascular endothelial growth factor gene expression in ovine placenta and fetal membranes. Am. J. Obstet. Gynecol 173, 753-759.[Medline]

Chiang, M. K. and Flanagan, J. G (1995). Interactions between the Flk-1 receptor, vascular endothelial growth factor, and cell surface proteoglycan identified with a soluble receptor reagent. Growth Factors 12, 1-10.[Medline]

Claffey, K. P., Wilkison, W. O. and Spiegelman, B. M (1992). Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J. Biol. Chem 267, 16317-16322.[Abstract/Free Full Text]

Claffey, K. P., Senger, D. R. and Spiegelman, B. M (1995). Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGF. Biochim. Biophys. Acta 1246, 1-9.[Medline]

Clark, D. E., Smith, S. K., He, Y., Day, K. A., Licence, D. R., Corps, A. N. Lammoglia, R. and Charnock-Jones, D. S (1998). A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol. Reprod 59, 1540-1548.[Abstract/Free Full Text]

Clauss, M., Gerlach, M., Gerlach, H., Brett, J., Wang, F., Familletti, P. C., Pan, Y. C., Olander, J. V., Connolly, D. T. and Stern, D (1990). Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med 172, 1535-1545.[Abstract/Free Full Text]

Clauss, M., Weich, H., Breier, G., Knies, U., Rockl, W., Waltenberger, J. and Risau, W (1996). The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem 271, 17629-17634.[Abstract/Free Full Text]

Cohen, T., Gitay-Goren, H., Sharon, R., Shibuya, M., Halaban, R., Levi, B. Z., Neufeld, G (1995). VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J. Biol. Chem 270, 11322-11326.[Abstract/Free Full Text]

Connolly, D. T., Olander, J. V., Heuvelman, D., Nelson, R., Monsell, R., Siegel, N., Haymore, B. L., Leimgruber, R. and Feder, J (1989). Human vascular permeability factor. Isolation from U937 cells. J. Biol. Chem 264, 20017-20024.[Abstract/Free Full Text]

Davis-Smyth, T., Chen, H., Park, J., Presta, L. G. and Ferrara, N (1996). The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J 15, 4919-4927.[Medline]

de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N. and Williams, L. T (1992). The fms -like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 55, 989-991.

Dibbens, J. A., Miller, D. L., Damert, A., Risau, W., Vadas, M. A. and Goodall, G. J (1999). Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol. Biol. Cell 10, 907-919.[Abstract/Free Full Text]

DiSalvo, J., Bayne, M. L., Conn, G., Kwok, P. W., Trivedi, P. G., Soderman, D. D., Palisi, T. M., Sullivan, K. A. and Thomas, K. A (1995). Purification and characterization of a naturally occurring vascular endothelial growth factor/placenta growth factor heterodimer. J. Biol. Chem 270, 7717-7723.[Abstract/Free Full Text]

Dougher, A. M., Wasserstrom, H., Torley, L., Shridaran, L., Westdock, P., Hileman, R. E., Fromm, J. R., Anderberg, R., Lyman, S., Linhardt, R. J., Kaplan, J. and Terman, B. I (1997). Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor. Growth Factors 14, 257-268.[Medline]

Dumont, D. J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., Breitman, M. and Alitalo, K (1998). Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282, 946-949.[Abstract/Free Full Text]

Eichmann, A., Corbel, C., Nataf, V., Vaigot, P., Breant, C. and Le-Douarin, N. M (1997). Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascularendothelial growth factor receptor 2. Proc. Nat. Acad. Sci. USA 94, 5141-5146.[Abstract/Free Full Text]

Enholm, B., Paavonen, K., Ristimaki, A., Kumar, V., Gunji, Y., Klefstrom, J., Kivinen, L., Laiho, M., Olofsson, B., Joukov, V., Eriksson, U. and Alitalo, K (1997). Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 14, 2475-2483.[Medline]

Fairbrother, W. J., Champe, M. A., Christinger, H. W., Keyt, B. A. and Starovasnik, M. A (1998). Solution structure of the heparin-binding domain of vascular endothelial growth factor. Structure 6, 637-648.[Medline]

Farnebo, F., Piehl, F. and Lagercrantz, J (1999). Restricted expression pattern of VEGF-D in the adult and fetal mouse: high expression in the embryonic lung. Biochem. Biophys. Res. Commun 257, 891-894.[Medline]

Ferrara, N. and Henzel, W. J (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun 161, 851-858.[Medline]

Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., Moore, M. W (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.[Medline]

Ferrara, N. and Davis-Smyth, T (1997). The biology of vascular endothelial growth factor. Endocr. Rev 18, 4-25.[Abstract/Free Full Text]

Finnerty, H., Kelleher, K., Morris, G. E., Bean, K., Merberg, D. M., Kriz, R., Morris, J. C., Sookdeo, H., Turner, K. J. and Wood, C. R (1993). Molecular cloning of murine FLT and FLT4. Oncogene 8, 2293-2298.[Medline]

Folkman, J (1990). What is the evidence that tumors are angiogenesis dependent?. J. Nat. Cancer Inst 82, 4-6.[Free Full Text]

Folkman, J. and Hanahan, D (1991). Switch to the angiogenic phenotype during tumorigenesis. Princess Takamatsu Symp 22, 339-347.[Medline]

Folkman, J (1997). Angiogenesis and angiogenesis inhibition: an overview. EXS 79, 1-8.[Medline]

Fong, G. H., Rossant, J., Gertsenstein, M. and Breitman, M. L (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70.[Medline]

Fong, G. H., Zhang, L., Bryce, D. M. and Peng, J (1999). Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development 126, 3015-3025.[Abstract]

Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D. and Semenza, G. L (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol 16, 4604-4613.[Abstract]

Fuh, G., Li, B., Crowley, C., Cunningham, B. and Wells, J. A (1998). Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J. Biol. Chem 273, 11197-11204.[Abstract/Free Full Text]

Garrido, C., Saule, S. and Gospodarowicz, D (1993). Transcriptional regulation of vascular endothelial growth factor gene expression in ovarian bovine granulosa cells. Growth Factors 8, 109-117.[Medline]

Gengrinovitch, S., Greenberg, S. M., Cohen, T., Gitay-Goren, H., Rockwell, P., Maione-T. E., Levi, B. Z. and Neufeld, G (1995). Platelet factor-4 inhibits the mitogenic activity of VEGF121and VEGF165using several concurrent mechanisms. J. Biol. Chem 270, 15059-15065.[Abstract/Free Full Text]

Gengrinovitch, S., Berman, B., David, G., Witte, L., Neufeld, G. and Ron, D (1999). Glypican-1 is a VEGF165binding proteoglycan that acts as an extracellular chaperone for VEGF165. J. Biol. Chem 274, 10816-10822.[Abstract/Free Full Text]

Gerber, H. P., Condorelli, F., Park, J. and Ferrara, N (1997). Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J. Biol. Chem 272, 23659-23667.[Abstract/Free Full Text]

Giger, R. J., Urquhart, E. R., Gillespie, S. K., Levengood, D. V., Ginty, D. D. and Kolodkin, A. L (1998). Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity. Neuron 21, 1079-1092.[Medline]

Giraudo, E., Primo, L., Audero, E., Gerber, H. P., Koolwijk, P., Soker, S., Klagsbrun, M., Ferrara, N. and Bussolino, F (1998). Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J. Biol. Chem 273, 22128-22135.[Abstract/Free Full Text]

Gitay-Goren, H., Soker, S., Vlodavsky, I. and Neufeld, G (1992). The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem 267, 6093-6098.[Abstract/Free Full Text]

Gitay-Goren, H., Cohen, T., Tessler, S., Soker, S., Gengrinovitch, S., Rockwell, P., Klagsbrun, M., Levi, B. Z. and Neufeld, G (1996). Selective binding of VEGF121to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J. Biol. Chem 271, 5519-5523.[Abstract/Free Full Text]

Gospodarowicz, D., Abraham, J. A. and Schilling, J (1989). Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc. Nat. Acad. Sci. USA 86, 7311-7315.[Abstract/Free Full Text]

Grimmond, S., Lagercrantz, J., Drinkwater, C., Silins, G., Townson, S., Pollock, P., Gotley, D., Carson, E., Rakar, S., Nordenskjold, M., Ward, L., Hayward, N. and Weber, G (1996). Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Res 6, 124-131.[Abstract/Free Full Text]

Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B. and Marme, D (1995). Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem 270, 25915-25919.[Abstract/Free Full Text]

Grutzkau, A., Kruger-Krasagakes, S., Baumeister, H., Schwarz, C., Kogel, H., Welker, P., Lippert, U., Henz, B. M. and Moller, A (1998). Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol. Biol. Cell 9, 875-884.[Abstract/Free Full Text]

Guerrin, M., Moukadiri, H., Chollet, P., Moro, F., Dutt, K., Malecaze, F. and Plouet, J (1995). Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J. Cell. Physiol 164, 385-.[Medline]

Hauser, S. and Weich, H. A (1993). A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 9, 259-268.[Medline]

He, Y., Smith, S. K., Day, K. A., Clark, D. E., Licence, D. R. and Charnock-Jones, D. S (1999). Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol. Endocrinol 13, 537-545.[Abstract/Free Full Text]

He, Z. and Tessier-Lavigne, M (1997). Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 90, 739-751.[Medline]

Hiratsuka, S., Minowa, O., Kuno, J., Noda, T. and Shibuya, M (1998). Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Nat. Acad. Sci. USA 95, 9349-9354.[Abstract/Free Full Text]

Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B. and Leung, D. W (1991). The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol 5, 1806-1814.[Abstract]

Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J. and Ferrara, N (1992). Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem 267, 26031-26037.[Abstract/Free Full Text]

Igarashi, K., Isohara, T., Kato, T., Shigeta, K., Yamano, T. and Uno, I (1998). Tyrosine-1213 of Flt-1 is a major binding site of Nck and SHP-2. Biochem. Biophys. Res. Commun 246, 95-99.[Medline]

Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G. Jr and Goldberg, M. A (1996). Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Nat. Acad. Sci. USA 93, 10595-10599.[Abstract/Free Full Text]

Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K. and Alitalo, K (1997). Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423-1425.[Abstract/Free Full Text]

Jiang, B. H., Semenza, G. L., Bauer, C. and Marti, H. H (1996). Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2tension. Am. J. Physiol 271, 1172-1180.

Jingjing, L., Xue, Y., Agarwal, N. and Roque, R. S (1999). Human Muller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor. Invest. Ophthalmol. Vis. Sci 40, 752-759.[Abstract/Free Full Text]

Jonca, F., Ortega, N., Gleizes, P. E., Bertrand, N. and Plouet, J (1997). Cell release of bioactive fibroblast growth factor-2 by exon 6-encoded sequence of vascular endothelial growth factor. J. Biol. Chem 272, 24203-24209.[Abstract/Free Full Text]

Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N. and Alitalo, K (1996). A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15, 290-298.[Medline]

Joukov, V., Sorsa, T., Kumar, V., Jeltsch, M., Claesson-Welsh, L., Cao, Y., Saksela, O., Kalkkinen, N. and Alitalo, K (1997). Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO. J 16, 3898-3911.[Medline]

Joukov, V., Kaipainen, A., Jeltsch, M., Pajusola, K., Olofsson, B., Kumar, V., Eriksson, U. and Alitalo, K (1997). Vascular endothelial growth factors VEGF-B and VEGF-C. J. Cell. Physiol 173, 211-215.[Medline]

Kaipainen, A., Korhonen, J., Mustonen, T., van-Hinsbergh, V. W., Fang, G. H., Dumont, D., Breitman, M. and Alitalo, K (1995). Expression of the fms -like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Nat. Acad. Sci. USA 92, 3566-3570.[Abstract/Free Full Text]

Kawakami, A., Kitsukawa, T., Takagi, S. and Fujisawa, H (1996). Developmentally regulated expression of a cell surface protein, neuropilin, in the mouse nervous system. J. Neurobiol 29, 1-17.[Medline]

Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J. and Connolly, D. T (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309-1312.[Abstract/Free Full Text]

Kendall, R. L. and Thomas, K. A (1993). Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Nat. Acad. Sci. USA 90, 10705-10709.[Abstract/Free Full Text]

Kendall, R. L., Wang, G., DiSalvo, J. and Thomas, K. A (1994). Specificity of vascular endothelial cell growth factor receptor ligand binding domains. Biochem. Biophys. Res. Commun 201, 326-330.[Medline]

Kendall, R. L., Wang, G. and Thomas, K. A (1996). Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem. Biophys. Res. Commun 226, 324-238.[Medline]

Keyt, B. A., Nguyen, H. V., Berleau, L. T., Duarte, C. M., Park, J., Chen, H. and Ferrara, N (1996). Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol. Chem 271, 5638-5646.[Abstract/Free Full Text]

Keyt, B. A., Berleau, L. T., Nguyen, H. V., Chen, H., Heinsohn, H., Vandlen, R. and Ferrara, N (1996). The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J. Biol. Chem 271, 7788-7795.[Abstract/Free Full Text]

Kieser, A., Weich, H. A., Brandner, G., Marme, D. and Kolch, W (1994). Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9, 963-969.[Medline]

Kitsukawa, T., Shimono, A., Kawakami, A., Kondoh, H. and Fujisawa, H (1995). Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 121, 4309-4318.[Abstract]

Kitsukawa, T., Shimizu, M., Sanbo, M., Hirata, T., Taniguchi, M., Bekku, Y., Yagi, T. and Fujisawa, H (1997). Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron 19, 995-1005.[Medline]

Kolodkin, A. L., Levengood, D. V., Rowe, E. G., Tai, Y. T., Giger, R. J. and Ginty, D. D (1997). Neuropilin is a semaphorin III receptor. Cell 90, 753-762.[Medline]

Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V. and Alitalo, K (1996). VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122, 3829-3837.[Abstract]

Landgren, E., Schiller, P., Cao, Y. and Claesson-Welsh, L (1998). Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1. Oncogene 16, 359-367.[Medline]

Lee, J., Gray, A., Yuan, J., Luoh, S. M., Avraham, H. and Wood, W. I (1996). Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt-4. Proc. Nat. Acad. Sci. USA 93, 1988-1992.[Abstract/Free Full Text]

Lei, J., Jiang, A. and Pei, D (1998). Identification and characterization of a new splicing variant of vascular endothelial growth factor: VEGF183. Biochim. Biophys. Acta 1443, 400-406.[Medline]

Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V. and Ferrara, N (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.[Abstract/Free Full Text]

Levy, A. P., Levy, N. S., Wegner, S. and Goldberg, M. A (1995). Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem 270, 13333-13340.[Abstract/Free Full Text]

Levy, N. S., Chung, S., Furneaux, H. and Levy, A. P (1998). Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem 273, 6417-6423.[Abstract/Free Full Text]

Li, J., Brown, L. F., Hibberd, M. G., Grossman, J. D., Morgan, J. P. and Simons, M (1996). VEGF, Flk-1, and Flt-1 expression in a rat myocardial infarction model of angiogenesis. Am. J. Physiol 270, 1803-1811.

Lindahl, U., Kusche-Gullberg, M. and Kjellen, L (1998). Regulated diversity of heparan sulfate. J. Biol. Chem 273, 24979-24982.[Free Full Text]

Liu, Y., Cox, S. R., Morita, T. and Kourembanas, S (1995). Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5enhancer. Circ. Res 77, 638-643.[Abstract/Free Full Text]

Lyttle, D. J., Fraser, K. M., Fleming, S. B., Mercer, A. A. and Robinson, A. J (1994). Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J. Virol 68, 84-92.[Abstract/Free Full Text]

Madan, A. and Curtin, P. T (1993). A 24-base-pair sequence 3to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer. Proc. Nat. Acad. Sci. USA 90, 3928-3932.[Abstract/Free Full Text]

Maeda, K., Chung, Y. S., Ogawa, Y., Takatsuka, S., Kang, S. M., Ogawa, M., Sawada, T. and Sowa, M (1996). Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77, 858-863.[Medline]

Maglione, D., Guerriero, V., Viglietto, G., Delli-Bovi, P. and Persico, M. G (1991). Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Nat. Acad. Sci. USA 88, 9267-9271.[Abstract/Free Full Text]

Maglione, D., Guerriero, V., Viglietto, G., Ferraro, M. G., Aprelikova, O., Alitalo, K., Del-Vecchio, S., Lei, K. J., Chou, J. Y. and Persico, M. G (1993). Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene 8, 925-931.[Medline]

Makinen, T., Olofsson, B., Karpanen, T., Hellman, U., Soker, S., Klagsbrun, M., Eriksson, U. and Alitalo, K (1999). Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1. J. Biol. Chem 274, 21217-21222.[Abstract/Free Full Text]

Matthews, W., Jordan, C. T., Gavin, M., Jenkins, N. A., Copeland, N. G. and Lemischka, I. R (1991). A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc. Nat. Acad. Sci. USA 88, 9026-9030.[Abstract/Free Full Text]

Mazure, N. M., Chen, E. Y., Yeh, P., Laderoute, K. R. and Giaccia, A. J (1996). Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res 56, 3436-3440.[Abstract/Free Full Text]

McDonald, N. Q. and Hendrickson, W. A (1993). A structural superfamily of growth factors containing a cystine knot motif. Cell 73, 421-424.[Medline]

Meyer, M., Clauss, M., Lepple-Wienhues, A., Waltenberger, J., Augustin, H. G., Ziche-M., Lanz, C., Buttner, M., Rziha, H. J. and Dehio, C (1999). A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J 18, 363-374.[Medline]

Miao, H. Q., Soker, S., Feiner, L., Alonso, J. L., Raper, J. A. and Klagsbrun, M (1999). Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell Biol 146, 233-242.[Abstract/Free Full Text]

Migdal, M., Huppertz, B., Tessler, S., Comforti, A., Shibuya, M., Reich, R., Baumann, H. and Neufeld, G (1998). Neuropilin-1 is a placenta growth factor-2 receptor. J. Biol. Chem 273, 22272-22278.[Abstract/Free Full Text]

Millauer, B., Wizigmann-Voos, S., Schnurch, H., Martinez, R., Moller, N. P., Risau, W. and Ullrich, A (1993). High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846.[Medline]

Minchenko, A., Bauer, T., Salceda, S. and Caro, J (1994). Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab. Invest 71, 374-379.[Medline]

Morishita, K., Johnson, D. E. and Williams, L. T (1995). A novel promoter for vascular endothelial growth factor receptor ( flt-1 ) that confers endothelial-specific gene expression. J. Biol. Chem 270, 27948-27953.[Abstract/Free Full Text]

Mukhopadhyay, D., Tsiokas, L. and Sukhatme, V. P (1995). Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 55, 6161-6165.[Abstract/Free Full Text]

Mukhopadhyay, D., Knebelmann, B., Cohen, H. T., Ananth, S. and Sukhatme, V. P (1997). The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol. Cell. Biol 17, 5629-5639.[Abstract]

Muller, Y. A., Christinger, H. W., Keyt, B. A. and de Vos, A. M (1997). The crystal structure of vascular endothelial growth factor (VEGF) refined to 1. 93 \201 resolution: multiple copy flexibility and receptor binding. Structure 5, 1325-1338.[Abstract/Free Full Text]

Murray-Rust, J., McDonald, N. Q., Blundell, T. L., Hosang, M., Oefner, C., Winkler, F. and Bradshaw, R. A (1993). Topological similarities in TGF-2, PDGF-BB and NGF define a superfamily of polypeptide growth factors. Structure 1, 153-159.[Medline]

Ogawa, S., Oku, A., Sawano, A., Yamaguchi, S., Yazaki, Y. and Shibuya, M (1998). A novel type of vascular endothelial growth factor, VEGF-E(NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J. Biol. Chem 273, 31273-31282.[Abstract/Free Full Text]

Olofsson, B., Pajusola, K., Kaipainen, A., von-Euler, G., Joukov, V., Saksela, O., Orpana, A., Pettersson, R. F., Alitalo, K. and Eriksson, U (1996). Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc. Nat. Acad. Sci. USA 93, 2576-2581.[Abstract/Free Full Text]

Olofsson, B., Pajusola, K., von-Euler, G., Chilov, D., Alitalo, K. and Eriksson, U (1996). Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J. Biol. Chem 271, 19310-19317.[Abstract/Free Full Text]

Olofsson, B., Korpelainen, E., Pepper, M. S., Mandriota, S. J., Aase, K., Kumar, V., Gunji, Y., Jeltsch, M. M., Shibuya, M., Alitalo, K. and Eriksson, U (1998). Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc. Nat. Acad. Sci. USA 95, 11709-11714.[Abstract/Free Full Text]

Omura, T., Miyazawa, K., Ostman, A. and Heldin, C. H (1997). Identification of a 190-kDa vascular endothelial growth factor 165 cell surface binding protein on a human glioma cell line. J. Biol. Chem 272, 23317-23322.[Abstract/Free Full Text]

Orlandini, M., Marconcini, L., Ferruzzi, R. and Oliviero, S (1996). Identification of a c- fos -induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc. Nat. Acad. Sci. USA 93, 11675-11680.[Abstract/Free Full Text]

Pajusola, K., Aprelikova, O., Korhonen, J., Kaipainen, A., Pertovaara, L., Alitalo, R. and Alitalo, K (1992). FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res 52, 5738-5743.[Abstract/Free Full Text]

Pal, S., Claffey, K. P., Dvorak, H. F. and Mukhopadhyay, D (1997). The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways. J. Biol. Chem 272, 27509-27512.[Abstract/Free Full Text]

Park, J. E., Keller, G. A. and Ferrara, N (1993). The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell 4, 1317-1326.[Abstract]

Park, J. E., Chen, H. H., Winer, J., Houck, K. A. and Ferrara, N (1994). Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem 269, 25646-25654.[Abstract/Free Full Text]

Park, M. and Lee, S. T (1999). The fourth immunoglobulin-like loop in the extracellular domain of FLT-1, a VEGF receptor, includes a major heparin-binding site. Biochem. Biophys. Res. Commun 264, 730-734.[Medline]

Patterson, C., Perrella, M. A., Hsieh, C. M., Yoshizumi, M., Lee, M. E. and Haber, E (1995). Cloning and functional analysis of the promoter for KDR/ flk -1, a receptor for vascular endothelial growth factor. J. Biol. Chem 270, 23111-23118.[Abstract/Free Full Text]

Pekala, P., Marlow, M., Heuvelman, D. and Connolly, D (1990). Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J. Biol. Chem 265, 18051-18054.[Abstract/Free Full Text]

Pepper, M. S., Ferrara, N., Orci, L. and Montesano, R (1991). Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun 181, 902-906.[Medline]

Pepper, M. S. and Mandriota, S. J (1998). Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells. Exp. Cell. Res 241, 414-425.[Medline]

Pepper, M. S., Mandriota, S. J., Jeltsch, M., Kumar, V. and Alitalo, K (1998). Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity. J. Cell. Physiol 177, 439-452.[Medline]

Peretz, D., Gitay-Goren, H., Safran, M., Kimmel, N., Gospodarowicz, D. and Neufeld, G (1992). Glycosylation of vascular endothelial growth factor is not required for its mitogenic activity. Biochem. Biophys. Res. Commun 182, 1340-1347.[Medline]

Persico, M. G., Vincenti, V. and DiPalma, T (1999). Structure, expression and receptor-binding properties of placenta growth factor (PlGF). Curr. Top. Microbiol. Immunol 237, 31-40.[Medline]

Pertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O. and Alitalo, K (1994). Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J. Biol. Chem 269, 6271-6274.[Abstract/Free Full Text]

Peters, K. G., De Vries, C. and Williams, L. T (1993). Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Nat. Acad. Sci. USA 90, 8915-8919.[Abstract/Free Full Text]

Petrova, T. V., Makinen, T. and Alitalo, K (1999). Signaling via vascular endothelial growth factor receptors. Exp. Cell. Res 253, 117-130.[Medline]

Piossek, C., Schneider-Mergener, J., Schirner, M., Vakalopoulou, E., Germeroth, L. and Thierauch, K. H (1999). Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF. J. Biol. Chem 274, 5612-5619.[Abstract/Free Full Text]

Plate, K. H., Breier, G., Weich, H. A. and Risau, W (1992). Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359, 845-848.[Medline]

Plouet, J., Schilling, J. and Gospodarowicz, D (1989). Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 8, 3801-3806.[Medline]

Plouet, J., Moro, F., Bertagnolli, S., Coldeboeuf, N., Mazarguil, H., Clamens, S. and Bayard, F (1997). Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect. J. Biol. Chem 272, 13390-13396.[Abstract/Free Full Text]

Poltorak, Z., Cohen, T., Sivan, R., Kandelis, Y., Spira, G., Vlodavsky, I., Keshet, E. and Neufeld, G (1997). VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J. Biol. Chem 272, 7151-7158.[Abstract/Free Full Text]

Potgens, A. J., Lubsen, N. H., van-Altena, M. C., Vermeulen, R., Bakker, A., Schoenmakers, J. G., Ruiter, D. J. and de-Waal, R. M (1994). Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. J. Biol. Chem 269, 32879-32885.[Abstract/Free Full Text]

Praloran, V., Mirshahi, S., Favard, C., Moukadiri, H. and Plouet, J (1991). Mitogenic activity of vasculotropin for peripheral human lymphocytes. C. R. Acad. Sci. III 313, 21-26.[Medline]

Quinn, T. P., Peters, K. G., de Vries, C., Ferrara, N. and Williams, L. T (1993). Fetal liver kinase-1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Nat. Acad. Sci. USA 90, 7533-7537.[Abstract/Free Full Text]

Rak, J., Filmus, J., Finkenzeller, G., Grugel, S., Marme, D. and Kerbel, R. S (1995). Oncogenes as inducers of tumor angiogenesis. Cancer Metast. Rev 14, 263-277.[Medline]

Salceda, S., Beck, I. and Caro, J (1996). Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia. Arch. Biochem. Biophys 334, 389-394.[Medline]

Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S. and Shibuya, M (1995). A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10, 135-147.[Medline]

Semenza, G. L., Agani, F., Booth, G., Forsythe, J., Iyer, N., Jiang, B. H., Leung, S., Roe, R., Wiener, C. and Yu, A (1997). Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int 51, 553-555.[Medline]

Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V.S.and Dvorak, H. F (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985.[Abstract/Free Full Text]

Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., Schuh, A. C (1995). Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature 376, 62-66.[Medline]

Sheibani, N. and Frazier, W. A (1998). Down-regulation of platelet endothelial cell adhesion molecule-1 results in thrombospondin-1 expression and concerted regulation of endothelial cell phenotype. Mol. Biol. Cell 9, 701-713.[Abstract/Free Full Text]

Shen, B. Q., Lee, D. Y., Gerber, H. P., Keyt, B. A. Ferrara, N. and Zioncheck, T. F (1998). Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J. Biol. Chem 273, 29979-29985.[Abstract/Free Full Text]

Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H. and Sato, M (1990). Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene ( flt ) closely related to the fms family. Oncogene 5, 519-524.[Medline]

Shinkai, A., Ito, M., Anazawa, H., Yamaguchi, S., Shitara, K. and Shibuya, M (1998). Mapping of the sites involved in ligand association and dissociation at the extracellular domain of the kinase insert domain-containing receptor for vascular endothelial growth factor. J. Biol. Chem 273, 31283-31288.[Abstract/Free Full Text]

Shweiki, D., Itin, A., Soffer, D. and Keshet, E (1992). Vascular endothelialgrowth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845.[Medline]

Siemeister, G., Weindel, K., Mohrs, K., Barleon, B., Martiny-Baron, G. and Marme, D (1996). Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res 56, 2299-2301.[Abstract/Free Full Text]

Siemeister, G., Schirner, M., Reusch, P., Barleon, B., Marme, D. and Martiny-Baron, G (1998). An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells. Proc. Nat. Acad. Sci. USA 95, 4625-4629.[Abstract/Free Full Text]

Siemeister, G., Marme, D. and Martiny-Baron, G (1998). The alpha-helical domain near the amino terminus is essential for dimerization of vascular endothelial growth factor. J. Biol. Chem 273, 11115-11120.[Abstract/Free Full Text]

Soker, S., Svahn, C. M. and Neufeld, G (1993). Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin. J. Biol. Chem 268, 7685-7691.[Abstract/Free Full Text]

Soker, S., Fidder, H., Neufeld, G. and Klagsbrun, M (1996). Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165via its exon 7-encoded domain. J. Biol. Chem 271, 5761-5767.[Abstract/Free Full Text]

Soker, S., Takashima, S., Miao, H. Q., Neufeld, G. and Klagsbrun, M (1998). Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745.[Medline]

Sondell, M., Lundborg, G. and Kanje, M (1999). Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci 19, 5731-5740.[Abstract/Free Full Text]

Stein, I., Itin, A., Einat, P., Skaliter, R., Grossman, Z. and Keshet, E (1998). Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol. Cell. Biol 18, 3112-3119.[Abstract/Free Full Text]

Stratmann, R., Krieg, M., Haas, R. and Plate, K. H (1997). Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene. J. Neuropathol. Exp. Neurol 56, 1242-1252.[Medline]

Stringer, S. E. and Gallagher, J. T (1997). Heparan sulphate. Int. J. Biochem. Cell. Biol 29, 709-714.[Medline]

Sugihara, T., Wadhwa, R., Kaul, S. C. and Mitsui, Y (1998). A novel alternatively spliced form of murine vascular endothelial growth factor, VEGF115. J. Biol. Chem 273, 3033-3038.[Abstract/Free Full Text]

Sun, P. D. and Davies, D. R (1995). The cystine-knot growth-factor superfamily. Annu. Rev. Biophys. Biomol. Struct 24, 269-291.[Medline]

Takagi, H., King, G. L., Robinson, G. S., Ferrara, N. and Aiello, L. P (1996). Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest. Ophthalmol. Vis. Sci 37, 2165-2176.[Abstract/Free Full Text]

Takagi, S., Kasuya, Y., Shimizu, M., Matsuura, T., Tsuboi, M., Kawakami, A. and Fujisawa, H (1995). Expression of a cell adhesion molecule, neuropilin, in the developing chick nervous system. Dev. Biol 170, 207-222.[Medline]

Takahashi, T. and Shibuya, M (1997). The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene 14, 2079-2089.[Medline]

Terman, B. I., Carrion, M. E., Kovacs, E., Rasmussen, B. A., Eddy, R. L. and Shows, T. B (1991). Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6, 1677-1683.[Medline]

Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D. and Bohlen, P (1992). Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun 187, 1579-1586.[Medline]

Terman, B., Khandke, L., Dougher-Vermazan, M., Maglione, D., Lassam, N. J., Gospodarowicz, D., Persico, M. G., Bohlen, P. and Eisinger, M (1994). VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. Growth Factors 11, 187-195.[Medline]

Tessler, S., Rockwell, P., Hicklin, D., Cohen, T., Levi, B. Z., Witte, L., Lemischka, I. R. and Neufeld, G (1994). Heparin modulates the interaction of VEGF165with soluble and cell associated Flk-1 receptors. J. Biol. Chem 269, 12456-12461.[Abstract/Free Full Text]

Thieme, H., Aiello, L. P., Takagi, H., Ferrara, N. and King, G. L (1995). Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes 44, 98-103.[Abstract]

Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C. and Abraham, J. A (1991). The human gene for vascularendothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem 266, 11947-11954.[Abstract/Free Full Text]

Toi, M., Hoshina, S., Takayanagi, T., Tominaga, T (1994). Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J. Cancer Res 85, 1045-1049.[Medline]

Tordjman, R., Ortega, N., Coulombel, L., Plouet, J., Romeo, P. H. and Lemarchandel, V (1999). Neuropilin-1 is expressed on bone marrow stromal cells: a novel interaction with hematopoietic cells?. Blood 94, 2301-2309.[Abstract/Free Full Text]

Tuder, R. M., Flook, B. E. and Voelkel, N. F (1995). Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J. Clin. Invest 95, 1798-1807.

Unemori, E. N., Ferrara, N., Bauer, E. A. and Amento, E. P (1992). Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J. Cell. Physiol 153, 557-562.[Medline]

Vincenti, V., Cassano, C., Rocchi, M. and Persico, G (1996). Assignment of the vascular endothelial growth factor gene to human chromosome 6p21. 3. Circulation 93, 1493-1495.[Abstract/Free Full Text]

Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M. and Heldin, C. H (1994). Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem 269, 26988-26995.[Abstract/Free Full Text]

Waltenberger, J., Mayr, U., Pentz, S. and Hombach, V (1996). Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation 94, 1647-1654.[Abstract/Free Full Text]

Wang, H. and Keiser, J. A (1998). Vascular endothelial growth factorupregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of Flt-1. Circ. Res 83, 832-840.[Abstract/Free Full Text]

Wen, Y., Edelman, J. L., Kang, T., Zeng, N. and Sachs, G (1998). Two functional forms of vascular endothelial growth factor receptor-2/Flk-1 mRNA are expressed in normal rat retina. J. Biol. Chem 273, 2090-2097.[Abstract/Free Full Text]

Wiesmann, C., Fuh, G., Christinger, H. W., Eigenbrot, C., Wells, J. A. and de Vos, A. M (1997). Crystal structure at 1.7 \201 resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 91, 695-704.[Medline]

Wilting, J., Birkenhager, R., Eichmann, A., Kurz, H., Martiny-Baron, G., Marme, D., McCarthy, J. E., Christ, B. and Weich, H. A (1996). VEGF121induces proliferation of vascular endothelial cells and expression of Flk-1 without affecting lymphatic vessels of chorioallantoic membrane. Dev. Biol 176, 76-85.[Medline]

Wise, L. M., Veikkola, T., Mercer, A. A., Savory, L. J., Fleming, S. B., Caesar, C., Vitali, A., Makinen, T., Alitalo, K. and Stacker, S. A (1999). Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc. Nat. Acad. Sci. USA 96, 3071-3076.[Abstract/Free Full Text]

Witzenbichler, B., Asahara, T., Murohara, T., Silver, M., Spyridopoulos, I., Magner, M., Principe, N., Kearney, M., Hu, J. S. and Isner, J. M (1998). Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am. J. Pathol 153, 381-394.[Abstract/Free Full Text]

Yamada, Y., Nezu, J., Shimane, M. and Hirata, Y (1997). Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics 42, 483-488.[Medline]

Zachary, I (1998). Vascular endothelial growth factor: how it transmits its signal. Exp. Nephrol 6, 480-487.[Medline]


This article has been cited by other articles:


Home page
 IOVSHome page
C. Q. Yu, M. Zhang, K. I. Matis, C. Kim, and M. I. Rosenblatt
Vascular Endothelial Growth Factor Mediates Corneal Nerve Repair
Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 3870 - 3878.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
M. H. Criswell, W.-Z. Hu, T. J. Steffens, R. Li, and P. Margaron
Comparing Pegaptanib and Triamcinolone Efficacy in the Rat Choroidal Neovascularization Model
Arch Ophthalmol, July 1, 2008; 126(7): 946 - 952.
[Abstract] [Full Text] [PDF]

Home page
 Vet PatholHome page
P. J. Dickinson, B. K. Sturges, R. J. Higgins, B. N. Roberts, C. M. Leutenegger, A. W. Bollen, and R. A. LeCouteur
Vascular Endothelial Growth Factor mRNA Expression and Peritumoral Edema in Canine Primary Central Nervous System Tumors
Vet. Pathol., March 1, 2008; 45(2): 131 - 139.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
B. A. Bryan, T. E. Walshe, D. C. Mitchell, J. S. Havumaki, M. Saint-Geniez, A. S. Maharaj, A. E. Maldonado, and P. A. D'Amore
Coordinated Vascular Endothelial Growth Factor Expression and Signaling During Skeletal Myogenic Differentiation
Mol. Biol. Cell, March 1, 2008; 19(3): 994 - 1006.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Sivakumar, N. Sharma-Walia, H. Raghu, M. V. Veettil, S. Sadagopan, V. Bottero, L. Varga, R. Levine, and B. Chandran
Kaposi's Sarcoma-Associated Herpesvirus Induces Sustained Levels of Vascular Endothelial Growth Factors A and C Early during In Vitro Infection of Human Microvascular Dermal Endothelial Cells: Biological Implications
J. Virol., February 15, 2008; 82(4): 1759 - 1776.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
P. Mineur, A. C. Colige, Christophe. F. Deroanne, J. Dubail, F. Kesteloot, Y. Habraken, A. Noel, S. Voo, J. Waltenberger, C. M. Lapiere, et al.
Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents
J. Cell Biol., December 17, 2007; 179(6): 1261 - 1273.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
C. P. Thomas, J. I. Andrews, and K. Z. Liu
Intronic polyadenylation signal sequences and alternate splicing generate human soluble Flt1 variants and regulate the abundance of soluble Flt1 in the placenta
FASEB J, December 1, 2007; 21(14): 3885 - 3895.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. W. Ji, F. Mac Gabhann, and A. S. Popel
Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3740 - H3749.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Bahary, K. Goishi, C. Stuckenholz, G. Weber, J. LeBlanc, C. A. Schafer, S. S. Berman, M. Klagsbrun, and L. I. Zon
Duplicate VegfA genes and orthologues of the KDR receptor tyrosine kinase family mediate vascular development in the zebrafish
Blood, November 15, 2007; 110(10): 3627 - 3636.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Fischer, T. Gerriets, C. Wessels, M. Walberer, S. Kostin, E. Stolz, K. Zheleva, A. Hocke, S. Hippenstiel, and K. T. Preissner
Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor
Blood, October 1, 2007; 110(7): 2457 - 2465.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Krilleke, A. DeErkenez, W. Schubert, I. Giri, G. S. Robinson, Y.-S. Ng, and D. T. Shima
Molecular Mapping and Functional Characterization of the VEGF164 Heparin-binding Domain
J. Biol. Chem., September 21, 2007; 282(38): 28045 - 28056.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. Zygalaki, E. G. Tsaroucha, L. Kaklamanis, and E. S. Lianidou
Quantitative Real-Time Reverse Transcription PCR Study of the Expression of Vascular Endothelial Growth Factor (VEGF) Splice Variants and VEGF Receptors (VEGFR-1 and VEGFR-2) in Non Small Cell Lung Cancer
Clin. Chem., August 1, 2007; 53(8): 1433 - 1439.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. L. Springer, A. Banfi, J. Ye, G. von Degenfeld, P. E. Kraft, S. A. Saini, N. K. Kapasi, and H. M. Blau
Localization of vascular response to VEGF is not dependent on heparin binding
FASEB J, July 1, 2007; 21(9): 2074 - 2085.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
H. Harant, B. Wolff, E. P. Schreiner, B. Oberhauser, L. Hofer, N. Lettner, S. Maier, J. E. de Vries, and I. J. Lindley
Inhibition of Vascular Endothelial Growth Factor Cotranslational Translocation by the Cyclopeptolide CAM741
Mol. Pharmacol., June 1, 2007; 71(6): 1657 - 1665.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
L. Wilkinson, T. Gilbert, G. Kinna, L.-A. Ruta, D. Pennisi, M. Kett, and M. H. Little
Crim1KST264/KST264 Mice Implicate Crim1 in the Regulation of Vascular Endothelial Growth Factor-A Activity during Glomerular Vascular Development
J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1697 - 1708.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
V L Bosquiazzo, J G Ramos, J Varayoud, M Munoz-de-Toro, and E H Luque
Mast cell degranulation in rat uterine cervix during pregnancy correlates with expression of vascular endothelial growth factor mRNA and angiogenesis
Reproduction, May 1, 2007; 133(5): 1045 - 1055.
[Abstract] [Full Text] [PDF]